Novascope Biochips Inc.

Novascope Biochips Inc. is a diagnostic platform developer pioneering next-generation point-of-care and laboratory diagnostics using proprietary BioChips Reaction (BCR) technology. The platform delivers ultra-high sensitivity detection of DNA, proteins, and small molecules with quick turnaround times, multiplexing capability, and minimal sample volumes. Applications span lab medicine, primary care, and point-of-care testing (POCT). The company emphasizes secure data transfer to mobile devices, making results accessible in clinical and home-care settings. Core strengths include affordability, rapid analysis, and comprehensive healthcare application coverage from centralized laboratory to decentralized primary care environments.